Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

VVOS Vivos Therapeutics Inc

2,13

0,00 (0,00%)

23 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Vivos Therapeutics (NASDAQ:VVOS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Vivos Therapeutics Charts.

Vivos Therapeutics (NASDAQ:VVOS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Vivos Therapeutics Charts.

News Vivos Therapeutics Inc

Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors
Montag 20 Mai 2024 (3 Tage vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 17 Mai 2024 (5 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 15 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
Dienstag 14 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
Dienstag 14 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Dienstag 9 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
Donnerstag 28 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
Donnerstag 28 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds
Donnerstag 15 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Vivos Therapeutics Inc News-Artikel

Jayex Technology

Legato Merger Corp III

Customers Bancorp

Vontobel Financial Produ...

BlackRock Institutional ...

Vanguard Ohio Tax-Exempt Money M

Frk Cem Dbt Etf

VPC Specialty Lending In... (GM)

SoftwareONE (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen